Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3

References

• Jenkins RB, Tefferi A, Solberg LA, Dewald GW. Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3. Cancer Genet Cytogenet. 1989;39:167–79.
   PubMed Web of Science ®Google Scholar
• Jotterand M, Parlier V, Mühlematter D, Grob JP, Beris Ph. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genet Cytogenet. 1992;59:138–60.
   PubMed Web of Science ®Google Scholar
• Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig WD, et al. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). Leukemia 1994;8:1318–26.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Lee Harris N, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC press; 2008.
   Google Scholar
• Levy ER, Parganas E, Morishita K, Fichelson S, James L, Oscier D, Gisselbrecht S, Ihle JN, Bucle VJ. DNA rearrangements proximal to the EVI 1 locus associated with the 3q21q26 syndrome. Blood 1994;83:1348–54.
   PubMed Web of Science ®Google Scholar
• Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G, et al. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. Haematologica 2003;88:1221–8.
   PubMed Web of Science ®Google Scholar
• Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003;101:837–45.
   PubMed Web of Science ®Google Scholar
• Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, et al. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica 2014;99:821–9.
   PubMed Web of Science ®Google Scholar
• Cui W, Sun J, Cotta CV, Medeiros J, Lin P. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia. Am J Clin Pathol. 2011;136:282–8.
   PubMed Web of Science ®Google Scholar
• Testoni N, Borsaru G, Martinelli G, Carboni C, Ruggeri D, Ottaviani E, et al. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica 1999;84:690–4.
   PubMed Web of Science ®Google Scholar
• Weisser M, Haferlach C, Haferlach T, Schnittger S. Advances age and high initial WBC influence the outcome of inv(3)(q21q26)/t(3;3)(q21;q26) positive AML. Leuk Lymphoma 2007;48:2145–51.
   PubMed Web of Science ®Google Scholar
• Medeiros BC, Kohrt HE, Arber DA, Bangs Cd, Cherry AM, Majeti R, Kogel KE, Azar CA, Patel S, Alizadeh AA. Inmunophenotypic features of acute myeloid leukaemia with inv(3)(q21q26.2)/t(3;3)(q21q26.2). Leuk Res. 2010;34:594–7.
   PubMed Web of Science ®Google Scholar
• Lugthart S, Gröschel S, Beverloo HB, Kayser S, Valk P, van Zelderen-Bhola SL, et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010;28:3890–98.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–65.
   PubMed Web of Science ®Google Scholar
• Haimi M, Elhasid R, Moustafa N, Gershoni-Baruch R. Aberration of 3q and monosomy 7 in a child with acute myelogenous leukemia. Cancer Genet Cytogenet. 2007;174:78–81.
   PubMed Web of Science ®Google Scholar
• Sun J, Konoplev SN, Wang X, Cui W, Chen SS, Medeiros LJ, et al. De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification. Mod Pathol. 2011;24:384–9.
   PubMed Web of Science ®Google Scholar
• Chung HJ, Seo EJ, Kim KH, Jang S, Park CJ, Lee HJ, et al. Hematologic and clinical features of 3q21q26 syndrome: extremely poor prognosis and association with central diabetes insipidus. Korean J Lab Med. 2007;27:133–8.
   PubMed Web of Science ®Google Scholar
• Reiter E, Greinix H, Rabitsch W, Keil F, Schwarzinger I, Jaeger U, et al. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3)(q21q26). Ann Hematol. 2000;79:374–7.
   PubMed Web of Science ®Google Scholar
• Horsman DE, Gascoyne RD, Barnett MJ. Acute leukaemia with structural rearrangements of chromosome 3. Leuk Lymphoma 1995;16:369–77.
   PubMed Web of Science ®Google Scholar
• Lim G, Kim MJ, Oh SH, Cho SY, Lee HJ, Suh JT, et al. Acute myeloid leukemia associated with t(1;3)(p36;q21) and extreme thrombocytosis: a clinical study with literature review. Cancer Genet Cytogenet. 2010;203:187–92.
   PubMed Web of Science ®Google Scholar
• Granada I, Luño E, Ribera JM, Sanzo C, Sancho JM, Muñiz SG, et al. Translocation (3;10)(q26;q22): a new nonrandom abnormality in three patients with 3q26 Involvement. Cancer Genet Cytogenet. 2000;121:99–100.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Nagata K, Tsurukubo Y, Morishita K, Hamaguchi H. A novel translocation t(3;22)(q21;q11) involving 3q21 in myelodysplastic syndrome-derived overt leukemia with thrombocytosis. Leuk Res. 2000;24:435–57.
   Web of Science ®Google Scholar
• Chang VT, Aviv H, Howard LM, Padberg F. Acute myelogenous leukemia associated with extreme symptomatic thrombocytosis and chromosome 3q translocation: case report and review of literature. Am J Hematol. 2003;72:20–26.
   PubMed Web of Science ®Google Scholar
• Yamagata N, Shimazaki C, Kikuta T, Hirai H, Sumikuma T, Sudo Y, et al. A translocation between 3q21 and 12q24 in a patient with minimally differentiated acute myeloidleukemia (AML-M0). Cancer Genet Cytogenet. 1997;97:90–93.
   PubMed Web of Science ®Google Scholar
• Li S, Yin C, Medeiros J, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol. 2012;138:146–52.
   PubMed Web of Science ®Google Scholar